Skip to content

Opening book details…

Can I read How to Get the Optimal Defibrillation Lead Parameters Using Myocardial Perfusion Scintigraphy in Patients with Coronary Artery Disease on EtoBox?

How to Get the Optimal Defibrillation Lead Parameters Using Myocardial Perfusion Scintigraphy in Patients with Coronary Artery Disease by Tariel A. Atabekov; Roman E. Batalov; Svetlana I. Sazonova; Sergey N. Krivolapov; Mikhail S. Khlynin; Anna I. Mishkina; Konstantin V. Zavadovsky; Antonio Curnis; Sergey V. Popov is a Medicine article available to read on EtoBox.

What is How to Get the Optimal Defibrillation Lead Parameters Using Myocardial Perfusion Scintigraphy in Patients with Coronary Artery Disease about?

The conventional criteria for a defibrillation lead (DL) implantation don't take into account presence of scar or deep ischemia in the myocardium. This may impair a proper functioning of the DL. We sought to optimize the DL implantation placement using rest myocardial perfusion scintigraphy (MPS), which allow detecting areas of myocardial hypoperfusion (MH). To study the influence of MH and scarring, detected by MPS, on the DL parameters in patients with coronary artery disease (CAD). 69 patients (male-65, age 64.8 ± 7.7 years) with CAD and indications for ICD implantation were enrolled. Two days before ICD implantation all patients underwent MPS at rest. Then patients were divided in 2 groups. In the 1st group DL was implanted considering MPS results: to the septal position, if the most significant MH were detected in the apical segments, and to the apical position, if MH were in the septal segments. In the 2nd group DL was implanted using the conventional approach without considering MPS results. Clinical 12 months follow-up was performed with ICD interrogation. Patients of both groups were comparable by clinical and scintigraphic parameters. In the same time, in the 1st group pa

Who reads How to Get the Optimal Defibrillation Lead Parameters Using Myocardial Perfusion Scintigraphy in Patients with Coronary Artery Disease?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Tariel A. Atabekov; Roman E. Batalov; Svetlana I. Sazonova; Sergey N. Krivolapov; Mikhail S. Khlynin; Anna I. Mishkina; Konstantin V. Zavadovsky; Antonio Curnis; Sergey V. Popov
Publisher
Springer Science and Business Media LLC
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by Tariel A. Atabekov; Roman E. Batalov; Svetlana I. Sazonova; Sergey N. Krivolapov; Mikhail S. Khlynin; Anna I. Mishkina; Konstantin V. Zavadovsky; Antonio Curnis; Sergey V. Popov

Browse all works by Tariel A. Atabekov; Roman E. Batalov; Svetlana I. Sazonova; Sergey N. Krivolapov; Mikhail S. Khlynin; Anna I. Mishkina; Konstantin V. Zavadovsky; Antonio Curnis; Sergey V. Popov